WASHINGTON, D.C. — February 23, 2026
The hemp industry is currently holding its collective breath as the Food and Drug Administration (FDA) prepares to release its official definition of a "container." Under the 2026 Continuing Appropriations and Extensions Act (CAEA), the 0.4mg total THC limit is applied per container.
However, the Act’s original language left a critical ambiguity: Does a "container" refer to the individual gummy wrapper, the multi-unit jar, or the bulk shipping vessel?
The Strategic Stakes for B2B Manufacturers
For B2B wholesalers, the FDA’s 90-day mandate (due by mid-February 2026) is the single most important document of the quarter. If the FDA defines a "container" as the innermost wrapping (e.g., a single-serving sachet), the industry may find a path toward "micro-dosed" high-efficacy products.
However, if the definition encompasses the entire retail jar, the current inventory of 10-count or 30-count CBD gummies will become federally non-compliant overnight.
Low Gravity’s Position: Modular Compliance
"We are advising our B2B partners to move toward modular packaging now," says a spokesperson for Low Gravity Hemp. By shifting to "Single-Unit" secondary packaging, brands can future-proof their inventory against the most restrictive FDA definitions.
At the top of the supply chain, Low Gravity is already re-tooling its formulation services to support high-precision, low-volume "Container-Max" dosing. You can source all you raw ingredient needs for scaled production that is regulatory ready.
